EMA Withdrawn: Trogarzo (Ibalizumab) — Theratechnologies Europe Limited

View source ↗

Summary

The EMA has withdrawn Trogarzo (ibalizumab) from Theratechnologies Europe Limited for treatment of HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Trogarzo (ibalizumab)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Theratechnologies Europe Limited. Decision date: 12/10/2022